课题基金 / 基金详情

A State-of-the-Art Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Alzheimer's Disease and Related Dementias

A State-of-the-Art Automatic Speech Recognition and Conversational Platform to Enable Socially Assistive Robots for Persons with Alzheimer's Disease and Related Dementias
最先进的自动语音识别和对话平台,为阿尔茨海默病和相关痴呆症患者提供社交辅助机器人
批准号:
10699887
负责人:
Chantal M Kerssens
金额:
$129.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2026-04-30

项目摘要

项目成果

Chantal M Kerssens的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 这个商业化准备试点(CRP)由care.coach公司(米尔布雷,加利福尼亚州)要求资金晚- 人工智能驱动对话技术的阶段性研究、开发和技术援助 一种与老年人一起开发并为老年人开发的智能(AI),特别是那些患有阿尔茨海默病的老年人 和相关痴呆症(ADRD)。过去的工作已经产生了社会辅助机器人(SAR)和虚拟健康 由人类监督的助手,以较低的成本改善健康状况,减少老年人的孤独感。 护理费用。客户忠诚度是世界一流的,远远超过净推广分数(100)为知名的 会话代理,证明产品的商业潜力。此外,第二阶段的积极供资 (5 R44 AG 0620 -14-03)已经产生了一个自动语音识别(ASR)引擎,该引擎在 理解老年人真正自然的语言,包括那些患有ADRD的人,而不是主要的转换AI 平台考虑到老年人,特别是那些 患有ADRD的患者,由于正常的年龄相关神经学变化或大脑病理学, 与ADRD有关。 利用这些进步和创新,care.coach正在为快速增长做准备,并吸引了 保险公司、大型保险公司的企业发展部门和传统投资者的兴趣相当大。 为了成功地扩展,我们建议在企业级集成的 知识解决方案,由KIE支持,KIE是一个开源平台,由KIE的Drools/jBPM规则和流程提供支持 机. KIE平台彻底改变了企业运营,并已被医疗保健行业采用, 通过从医疗保险索赔裁定到 实施临床决策支持系统。除了业务流程自动化之外, 销售商品(COGS)将通过培训在允许的用例中实现完全的会话自动化, 使用大型语言模型。这两种能力都将在拟议的CRP中使用最先进的 技术方法,并将在ADRD的复制研究中评价性能和可接受性 患者与健康计划和医疗提供者合作,为大量不同的老年人口提供服务。 这种技术援助和后期开发将提供最先进的、面向消费者的对话, 以工业化生产和自动化为技术平台, 确保一致和可扩展的数字医疗服务交付和制造的方法, 满足最高的安全性和消费者满意度标准。总体目标是改善健康状况, 5年内,数百万美国人的健康,包括那些患有ADRD的老年人。
英文摘要
ABSTRACT This commercialization readiness pilot (CRP) by care.coach corporation (Millbrae, CA) requests funds for late- stage research and development and technical assistance for a conversational technology driven by artificial intelligence (AI) that was developed with and for older adults, especially those aging with Alzheimer’s disease and related dementias (ADRD). Past work has resulted in a socially assistive robot (SAR) and virtual health assistant overseen by humans that improves health outcomes and reduces loneliness in older adults at a lower cost of care. Customer loyalty is world-class and far exceeds net promotor scores (NPS) for well-known conversational agents, attesting to the product’s commercial potential. Moreover, active Phase II funding (5R44AG0620-14-03) has resulted in an automated speech recognition (ASR) engine that is more accurate in understanding truly natural speech by older adults, including those with ADRD, than major conversional AI platforms. This is significant given the inherent challenges that the speech of older adults, especially of those with ADRD, poses to conversational AI due to normal age-related neurological changes or brain pathology associated with ADRD. Leveraging these advances and innovations, care.coach is preparing for rapid growth and has attracted considerable interest from insurers, corporate development arms of large insurers, and traditional investors. To successfully scale, we propose to re-platform our current system on top of an enterprise-grade, integrated knowledge solution enabled by KIE, an opensource platform powered by KIE’s Drools/jBPM rules and process engines. The KIE platform has revolutionized enterprise operations, and has been adopted in healthcare to drive quality and efficiency with applications ranging from the adjudication of health insurance claims to the implementation of clinical decision support systems. In addition to business process automation, the cost of goods sold (COGS) will come down with full conversational automation in allowable use cases by training and using a large language model. Both capabilities will be developed in the proposed CRP using state-of-the-art technical approaches, and will be evaluated for performance and acceptance in a replication study with ADRD patients in partnership with a health plan and medical providers that serve a large, diverse elderly population. This technical assistance and late-stage development will deliver a state-of-the-art, consumer-facing conversa- tional agent and virtual health assistant driven by a technology platform with industrial production and automa- tion methods that ensure consistent and scalable digital health service delivery and manufacturing, and that meet the highest security and consumer satisfaction standards. The overall goal is to improve the health and wellbeing of millions Americans within 5 years, including those aging with ADRD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Personalized Assistive Technology to Improve Dementia Care at Home
  • 批准号:
    8312419
  • 项目类别:
  • 资助金额:
    $31.02万
  • 财政年份:
    2012
  • 负责人:
    Chantal M Kerssens
  • 依托单位:
海外基金